Correlation Between Enfusion and Cemtrex
Can any of the company-specific risk be diversified away by investing in both Enfusion and Cemtrex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and Cemtrex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and Cemtrex, you can compare the effects of market volatilities on Enfusion and Cemtrex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of Cemtrex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and Cemtrex.
Diversification Opportunities for Enfusion and Cemtrex
Excellent diversification
The 3 months correlation between Enfusion and Cemtrex is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and Cemtrex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cemtrex and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with Cemtrex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cemtrex has no effect on the direction of Enfusion i.e., Enfusion and Cemtrex go up and down completely randomly.
Pair Corralation between Enfusion and Cemtrex
Given the investment horizon of 90 days Enfusion is expected to generate 0.15 times more return on investment than Cemtrex. However, Enfusion is 6.79 times less risky than Cemtrex. It trades about 0.23 of its potential returns per unit of risk. Cemtrex is currently generating about -0.22 per unit of risk. If you would invest 916.00 in Enfusion on August 27, 2024 and sell it today you would earn a total of 90.00 from holding Enfusion or generate 9.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enfusion vs. Cemtrex
Performance |
| Timeline |
| Enfusion |
| Cemtrex |
Enfusion and Cemtrex Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enfusion and Cemtrex
The main advantage of trading using opposite Enfusion and Cemtrex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, Cemtrex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cemtrex will offset losses from the drop in Cemtrex's long position.| Enfusion vs. ON24 Inc | Enfusion vs. Paycor HCM | Enfusion vs. E2open Parent Holdings | Enfusion vs. Braze Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |